Evidence map›Paper›PMID 38317929›Full record

ArticleHeliyon2024

Developing a versatile tool for studying kinetics of Selenate-Se removal from aqueous solution using a chemostat bioreactor.

Elnaz Mohammadi, Susan A Baldwin

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elnaz MohammadiChemical and Biological Engineering, University of British Columbia, 2360 East Mall, Vancouver, British Columbia, V6T 1Z3, Canada.
Susan A BaldwinChemical and Biological Engineering, University of British Columbia, 2360 East Mall, Vancouver, British Columbia, V6T 1Z3, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the impact of various parameters on the kinetics of dissolved selenium (Se) removal in bioreactors can be a challenging task, primarily due to the mass transfer limitations inherent in bioreactors employing attached growth configurations. This study successfully established a proof-of-concept for the efficient removal of Se from aqueous solutions using a chemostat bioreactor that relies solely on suspended growth. The research investigated the effect of selenate-Se feed concentrations under two distinct Se concentration conditions. One experiment was conducted at a considerably elevated concentration of 25 mg/L to impose stress on the system and evaluate its response. Another experiment replicated an environmentally relevant concentration of 1 mg/L, mirroring the typical Se concentrations in mine water. The bioreactor, featuring a working volume of 0.35 L, was operated as an anaerobic, fully mixed chemostat with hydraulic retention times (HRTs) ranging from 5 to 0.25 days. The outcomes revealed the chemostat's capacity to remove up to 25 mg/L of dissolved Se from water for all HRTs exceeding 1 day, under otherwise optimal conditions encompassing temperature, pH, and salinity. The research's significance lies in the development of a versatile tool designed to examine Se removal kinetics within a system devoid of mass transfer limitations. Furthermore, this study verified the ability of the bacterial consortium, obtained from a mine-influenced environment and enriched in the laboratory, to grow and sustain Se removal activities within a chemostat operating with HRTs as short as 1 day.

Indexed as

Bacterial consortiumChemostat bioreactorHydraulic retention timeKineticsSeleniumSuspended-growth

Identifiers

PMID38317929
PMCPMC10839987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.